VKTX
Viking Therapeutics, Inc.
+0.21 (+0.69%)29.73USD777K成交股數3.5B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-10-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 116M | 150M | 153M | 90.0M | 60.2M | 41.4M | 22.8M | 23.8M | 24.1M | 20.5M | 18.4M | 13.9M |
| 銷售管理費用 | 16.8M | 14.0M | 11.3M | 8.6M | 14.4M | 14.1M | 13.8M | 10.3M | 10.0M | 8.8M | 8.9M | 9.8M |
| 營業利益 | −133M+78% | −164M+196% | −165M+351% | −98.6M+189% | −74.6M+119% | −55.5M+89% | −36.6M+34% | −34.1M+43% | −34.1M | −29.3M | −27.3M | −23.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −128M+95% | −158M+247% | −158M+532% | −90.8M+308% | −65.6M+140% | −45.6M+85% | −24.9M+11% | −22.3M+16% | −27.4M | −24.6M | −22.5M | −19.2M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -1.10+90% | -1.37+234% | -1.39+532% | -0.81+305% | -0.58+123% | -0.41+71% | -0.22-4% | -0.20+5% | -0.26 | -0.24 | -0.23 | -0.19 |
| 稀釋股數 | 116M | 116M | 113M | 112M | 112M | 112M | 111M | 110M | 103M | 94.3M | 99.8M | 99.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 126M | 118M | 166M | 100M | 33.9M | 37.9M | 50.3M | 43.9M | 196M | 55.5M | 37.2M | 69.5M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 522M | 608M | 716M | 739M | 828M | 867M | 938M | 947M | 968M | 368M | 383M | 401M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 114M | 106M | 76.7M | 26.4M | 32.4M | 20.1M | 26.4M | 25.9M | 33.6M | 20.1M | 14.4M | 14.6M |
| 股東權益 | 408M | 502M | 639M | 713M | 795M | 847M | 911M | 921M | 934M | 348M | 368M | 386M |
| 負債比 | 21.8% | 17.5% | 10.7% | 3.6% | 3.9% | 2.3% | 2.8% | 2.7% | 3.5% | 5.4% | 3.8% | 3.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −114M+118% | – | – | – | −52.3M | – | – | −6.1M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | – | −360M | –% | -3.19 | – |
| FY2024 | 0.00 | – | −110M | –% | -1.01 | – |
| FY2023 | 0.00 | – | −85.9M | –% | -0.91 | – |
| FY2022 | 0.00 | – | −68.9M | –% | -0.90 | – |
| FY2021 | 0.00 | – | −55.0M | –% | -0.71 | – |
| FY2020 | 0.00 | – | −39.5M | –% | -0.54 | – |
| FY2019 | 0.00 | – | −25.8M | –% | -0.36 | – |
| FY2018 | 0.00 | – | −22.1M | –% | -0.38 | – |